NantOmics was last valued at $100M. It dates from May 2022. The company is private, so there is no listed share price.
One company valuation: $100M, dated May 2022.
No. NantOmics is a private company; its shares do not trade on a public exchange.
The last valuation is $100M.
Lead investors for each round are in the funding timeline.
The closest biotechnology / molecular diagnostics peers are on the competitors page.